Researcher profile · Semantic Scholar

M. Oleś

h-index: 8
Works: 24
Citations: 530

Most-cited papers

Drug-perturbation-based stratification of blood cancer
Sascha Dietrich, M. Oleś, Junyan Lu, L. Sellner +47 more
2017Journal of Clinical Investigation143 citations Open access
Semantic Scholar
Recurrent CDKN1B (p27) mutations in hairy cell leukemia.
S. Dietrich, J. Hüllein, S. Lee, B. Hutter +26 more
2015Blood94 citations Open access
Semantic Scholar
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
E. Andersson, S. Pützer, B. Yadav, O. Dufva +35 more
2017Leukemia91 citations
Semantic Scholar
Gain of CTCF-Anchored Chromatin Loops Marks the Exit from Naive Pluripotency
A. Pękowska, B. Klaus, Wanqing Xiang, Jacqueline Severino +8 more
2018Cell Systems77 citations Open access
Semantic Scholar
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity
L. Möhrmann, M. Werner, M. Oleś, A. Mock +40 more
2022Nature Communications50 citations Open access
Semantic Scholar
Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma
K. Tomska, R. Kurilov, K. Lee, J. Hüllein +8 more
2018Scientific Reports26 citations Open access
Semantic Scholar
Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependencies
M. Lukas, B. Velten, L. Sellner, K. Tomska +12 more
2020Leukemia20 citations Open access
Semantic Scholar
Dissection of CD20 regulation in lymphoma using RNAi
M. Słabicki, K. Lee, A. Jethwa, L. Sellner +19 more
2016Leukemia17 citations
Semantic Scholar
Neural lineage induction reveals multi-scale dynamics of 3D chromatin organization
A. Pękowska, B. Klaus, F. Klein, S. Anders +4 more
2014bioRxiv3 citations Open access
Semantic Scholar
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor
Marcus Renner, M. Oleś, N. Paramasivam, C. Heilig +42 more
2026Nature Communications2 citations Open access
Semantic Scholar
Abstract 919: Clinical relevance of comprehensive genomic analysis in patients with advanced-stage neuroendocrine neoplasms: Results from the MASTER trial of the German Cancer Consortium
S. Kreutzfeldt, L. Apostolidis, M. Oleś, P. Horák +20 more
2019Clinical research2 citations
Semantic Scholar
Prospective pan-cancer phosphoproteomics at clinical scale extends therapeutic options in precision oncology
Annika Schneider, Julia Wortmann, C. Jensen, Leonardo Estrada Duenas +70 more
2026bioRxiv1 citations Open access
Semantic Scholar
Clinical outcome of personalised treatment guided by genome and transcriptome sequencing in patients with neuroendocrine neoplasms: Updated results from the German NCT/DKTK MASTER trial
S. Kreutzfeldt, L. Apostolidis, M. Oleś, P. Horák +16 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
Prospective genome and transcriptome sequencing in advanced-stage neuroendocrine neoplasms.
Leonidas Apostolidis, S. Kreutzfeldt, M. Oleś, L. Gieldon +16 more
2018Annals of Oncology1 citations Open access
Semantic Scholar
DRUG PERTURBATION BASED STRATIFICATION OF LYMPHOPROLIFERATIVE DISORDERS
S. Dietrich, M. Oleś, L. Sellner, S. Anders +17 more
20171 citations Open access
Semantic Scholar
Discovery of Novel Drug Sensitivities in T-Prolymphocytic Leukemia (T-PLL) By High-Throughput Ex Vivo Drug Testing and Genetic Profiling
E. Andersson, L. Sellner, M. Oleś, T. Pemovska +13 more
20141 citations Open access
Semantic Scholar
Abstract 1028: A tumor-agnostic YAP/TAZ score predicts TEAD inhibitor sensitivity independent of Hippo alterations
Michael Wegert-Verhoeven, Mathea Fransisca, Sylvia Martin, Attila Jády +42 more
2026Cancer Research0 citations
Semantic Scholar
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.
S. Kreutzfeldt, L. Apostolidis, M. Oleś, E. Krieghoff-Henning +33 more
2026i Medicina0 citations Open access
Semantic Scholar
Abstract 926: Genomics-based personalized oncology of advanced thymic epithelial tumors
L. Möhrmann, L. Rostock, M. Oleś, A. Jahn +36 more
2023Cancer Research0 citations
Semantic Scholar
Abstract 820: Genomics based personalized oncology of cancer of unknown primary
M. Werner, L. Möhrmann, M. Oleś, A. Mock +25 more
2020Clinical research0 citations
Semantic Scholar
Pharmacogenomics of Primary Blood Cancer Cells
M. Oleś
20170 citations
Semantic Scholar
Abstract 2893: IGF2 is essential for tumor initiating cell activity in human colorectal cancer
Taronish D. Dubash, Christine Siegl, S. Dieter, J. Weischenfeldt +10 more
20170 citations
Semantic Scholar
Abstract 5557: Systematic mapping of drug sensitivity in hematological malignancies identifies vulnerability of chronic lymphocytic leukemia with mutant p53
L. Sellner, M. Oleś, M. Słabicki, C. Blume +21 more
20140 citations
Semantic Scholar
827: Ex vivo combinatorial screen to identify drug sensitivity and rational treatment of chronic lymphocytic leukemia
M. Lukas, L. Sellner, M. Oleś, J. Huellein +6 more
20140 citations
Semantic Scholar

E. Schröck

×9

B. Hutter×8

W. Huber×8

H. Glimm×8

S. Uhrig×7

J. Hüllein×6

B. Brors×6

C. Heining×6